ROBERT THOMAS DEVINCENZI, a director at $UTI, bought 1,000 shares of the company on 08-27-2026 for an estimated $21,800. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 0.7%. Following this trade, they now own 151,330 shares of this class of $UTI stock.
$UTI Insider Trading Activity
$UTI insiders have traded $UTI stock on the open market 14 times in the past 6 months. Of those trades, 4 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $UTI stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, LLC COLISEUM sold 3,000,000 shares for an estimated $124,200,000
- JEROME ALAN GRANT (Chief Executive Officer) has made 0 purchases and 2 sales selling 94,500 shares for an estimated $3,912,306.
- CHRISTOPHER E. KEVANE (EVP and Chief Legal Officer) sold 23,654 shares for an estimated $888,115
- TODD A HITCHCOCK (EVP/COO) sold 16,500 shares for an estimated $615,945
- LINDA J SRERE sold 15,000 shares for an estimated $548,800
- SHANNON LEI OKINAKA sold 10,000 shares for an estimated $347,414
- ROBERT THOMAS DEVINCENZI has made 4 purchases buying 11,000 shares for an estimated $295,186 and 0 sales.
- GEORGE W. BROCHICK sold 5,000 shares for an estimated $182,938
- KEVIN PREHN (Concorde Division President) sold 4,545 shares for an estimated $181,800
- CHRISTINE KLINE (Senior Vice President and CAO) sold 3,500 shares for an estimated $155,476
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$UTI Hedge Fund Activity
We have seen 158 institutional investors add shares of $UTI stock to their portfolio, and 133 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 3,930,523 shares (+108.5%) to their portfolio in Q2 2026, for an estimated $168,108,468
- COLISEUM CAPITAL MANAGEMENT, LLC removed 3,000,000 shares (-75.5%) from their portfolio in Q2 2026, for an estimated $128,310,000
- SHANNON RIVER FUND MANAGEMENT LLC added 890,113 shares (+inf%) to their portfolio in Q2 2026, for an estimated $38,070,133
- PRICE T ROWE ASSOCIATES INC /MD/ added 882,553 shares (+51.9%) to their portfolio in Q2 2026, for an estimated $37,746,791
- STATE STREET CORP added 854,169 shares (+82.4%) to their portfolio in Q2 2026, for an estimated $36,532,808
- CONGRESS ASSET MANAGEMENT CO added 847,617 shares (+39.4%) to their portfolio in Q2 2026, for an estimated $36,252,579
- GILDER GAGNON HOWE & CO LLC added 762,181 shares (+273.0%) to their portfolio in Q2 2026, for an estimated $32,598,481
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$UTI Revenue
$UTI had revenues of $218.9M in Q3 2026. This is an increase of 7.15% from the same period in the prior year.
You can track UTI financials on Quiver Quantitative's UTI stock page.
You can access data on UTI stock through the Quiver Quantitative API.
$UTI Price Targets
Multiple analysts have issued price targets for $UTI recently. We have seen 3 analysts offer price targets for $UTI in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Jasper Bibb from Truist Securities set a target price of $47.0 on 06/29/2026
- Alexander Paris from Barrington Research set a target price of $42.0 on 05/07/2026
- Steve Frankel from Rosenblatt set a target price of $45.0 on 05/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
